Hematology and Clinical Picture in Pediatric COVID-19 Infection
Pediatric COVID-19 Infection; Do Clinical Features and Hematological Parameters Predict the Need for ICU Admission?
1 other identifier
observational
29
1 country
1
Brief Summary
This study is to discuss the different clinical presentations, hematological and laboratory abnormalities in pediatric COVID-19 infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 24, 2020
CompletedFirst Posted
Study publicly available on registry
July 27, 2020
CompletedStudy Start
First participant enrolled
August 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 23, 2020
CompletedSeptember 9, 2020
September 1, 2020
8 days
July 24, 2020
September 6, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
hematological findings
hematological indices; TLC, absolute lymphocytic count, absolute neutrophil count platelet count, N/L ratio and CRP in pediatric COVID-19 infection
at time of admission
Secondary Outcomes (1)
clinical presentations
at time of admission
Eligibility Criteria
all pediatric patients who were admitted with confirmed COVID-19 infection with age range from birth to 18 years during the period from April 2020 till July 2020. The diagnosis of COVID-19 infection is based on positive SARS-CoV-2 RNA detection in throat swab specimens by PCR.
You may qualify if:
- inpatient confirmed COVID-19 infection by PCR
You may not qualify if:
- patients with records missing hematology and/or laboratory data,
- patients transfered to other medical facilities with unknown outcomes,
- patients with age older than 18 years from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Benha Universitylead
Study Sites (1)
Benha Faculty of Medicine
Banhā, Qalyubia Governorate, Egypt
Related Publications (2)
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
PMID: 32031570BACKGROUNDFan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, Mucheli SS, Kuperan P, Ong KH. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020 Jun;95(6):E131-E134. doi: 10.1002/ajh.25774. Epub 2020 Mar 19. No abstract available.
PMID: 32129508BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shaimaa R Abdelmaksoud, MD
Benha University
- STUDY CHAIR
Rana A Khashaba, MD
Benha University
- STUDY CHAIR
Effat H Assar, MD
Benha University
- STUDY CHAIR
Rasha S Eldesouky, MD
Benha University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD Lecturer pediatrics
Study Record Dates
First Submitted
July 24, 2020
First Posted
July 27, 2020
Study Start
August 12, 2020
Primary Completion
August 20, 2020
Study Completion
August 23, 2020
Last Updated
September 9, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share